Latest TB Stories
TB infections, a serious threat to monkeys and apes, previously had been difficult to detect
Immune Network Ltd. (IMMFF), announces the completion of a Phase II trial of a once-daily M. vaccae pill (V7) conducted by Immunitor in Ukraine.
Apramycin, already used in animals, shows promise against drug-resistant TB and other 'superbugs,' without hearing loss
Tuberculosis, now largely controlled in the industrialized world, remains a stubbornly persistent killer in most of Africa, as well as parts of Asia and South America.
Reducing tuberculosis transmission in geographic "hotspots" where infections are highest could significantly reduce TB transmission on a broader scale.
Biomedical engineers at UC Davis have developed a microfluidic chip to test for latent tuberculosis.
The tuberculosis vaccine is often used as a treatment for bladder cancer, and adding vitamin D might improve the vaccine’s effectiveness.
- A political dynamiter.